Medicure (MCUJF) Projected to Post Quarterly Earnings on Tuesday

Medicure (OTCMKTS:MCUJF) is projected to post its results after the market closes on Tuesday, May 19th. Analysts expect Medicure to post earnings of ($0.0439) per share and revenue of $3.6260 million for the quarter.

Medicure (OTCMKTS:MCUJF) last issued its quarterly earnings data on Thursday, April 23rd. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.25). The company had revenue of $6.13 million for the quarter, compared to analyst estimates of $3.62 million. Medicure had a negative net margin of 24.61% and a negative return on equity of 41.55%.

Medicure Stock Performance

MCUJF opened at $0.75 on Tuesday. The firm has a market capitalization of $7.83 million, a P/E ratio of -1.53 and a beta of 0.97. The stock’s 50 day moving average price is $0.83 and its two-hundred day moving average price is $0.84. The company has a quick ratio of 0.77, a current ratio of 1.02 and a debt-to-equity ratio of 0.03. Medicure has a 12-month low of $0.60 and a 12-month high of $0.97.

About Medicure

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical?care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.